AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicrag M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Auriga Labs

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glicrag M 80mg/500mg Tablet

DiaBeta Duo 80mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. DiaBeta Duo should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods or juice) is vital to counter hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glicrag M 80mg/500mg Tablet

No text was provided to rewrite.

Uses of Glicrag M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glicrag M 80mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Glicrag M 80mg/500mg tablets with a meal.

Common Side effects of Glicrag M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glicrag M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet; do not crush, chew, or divide it. Glicrag M 80mg/500mg tablets should be administered with food.

How Glicrag M 80mg/500mg Tablet works:

Gliclazide and Metformin, combined as Glicrag M 80mg/500mg tablets, offer dual action against diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glicrag M 80mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glicrag M 80mg/500mg tablets is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glicrag M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glicrag M 80mg/500mg tablets, potentially requiring dosage modification. Consult a physician for guidance. Glicrag M 80mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glicrag M 80mg/500mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is unsuitable for individuals with severe hepatic dysfunction.

What if you forget to take Glicrag M 80mg/500mg Tablet :

Should you forget to take your Glicrag M 80mg/500mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glicrag M 80mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glicrag M 80mg/500mg Tablet

Glicrag M 80mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus. This dual-action medication helps regulate blood sugar in adults, complementing a healthy diet and exercise regimen. Gliclazide stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose output and enhances insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Glicrag M 80mg/500mg Tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Serious, though infrequent, side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Glicrag M 80mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Indeed, Glicrag M 80mg/500mg tablets can result in lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Its occurrence is mitigated by excluding individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Presenting symptoms might encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glicrag M 80mg/500mg tablet use and seek immediate medical attention.
Indeed, prolonged Glicrag M 80mg/500mg Tablet consumption can lead to vitamin B12 insufficiency. This depletion arises from the medication's interference with gastric vitamin B12 uptake. Left unaddressed, this may result in anemia, neurological complications, paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive alterations, and gait instability. To mitigate these risks, supplemental vitamin B12 administration, at least annually, is recommended by some studies.
Patients with hypersensitivity to any Glicrag M 80mg/500mg Tablet ingredient or excipient should not take this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glicrag M 80mg/500mg tablets is unsafe. This combination may induce dangerously low blood glucose and heighten the risk of lactic acidosis.
Glicrag M 80mg/500mg tablets contain gliclazide and metformin, working together to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose output and increases insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glicrag M 80mg/500mg Tablet administration is linked to several common adverse reactions. These can manifest as hypoglycemia, altered taste perception, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Serious, though infrequent, side effects such as lactic acidosis may also occur. Prolonged use might result in vitamin B12 deficiency.
Indeed, Glicrag M 80mg/500mg Tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Indeed, Glicrag M 80mg/500mg Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. To mitigate risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Lactic acidosis symptoms might manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glicrag M 80mg/500mg Tablet use and seek immediate medical attention.
Indeed, prolonged Glicrag M 80mg/500mg Tablet consumption can lead to vitamin B12 insufficiency. This deficiency arises from the medication's disruption of vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this can result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Glicrag M 80mg/500mg Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. The medication should also be omitted in patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glicrag M 80mg/500mg tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Glicrag M 80mg/500mg Tabl...
45
MRP 55
18% off